Tensha Therapeutics

Tensha Therapeutics

Verified
Small molecule selective bromodomain inhibitors for treating cancer and other diseases.
  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

$0.0

round
N/A

$0.0

round

$535m

Valuation: $535m

Acquisition
Total Funding000k

Recent News about Tensha Therapeutics

Edit